Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Clindamycin
- Therapeutic area
- Anti-infectives
- Drug class
- Lincosamide antibacterials
- ATC
- J01
- Strength
- 300 mg
- Dosage form
- Capsule
- Pack
- 16's
- Registration no.
- 014499
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-09-23 03:18
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
No change in the official DRAP price is recorded for this pack (16's). Current price PKR 729.14, effective 1 Jul 2024.
Cite this price history
MedInfoBase. Dalacin C 300 mg, 16's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/dalacin-c-300-mg-014499-16s-pfizer-pakistan-limited/ (accessed 24 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 729.14 | 2024-07-01 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 014499Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.
